Acute and Acute Recurrent Pancreatitis: Pancreatic Disease

Ultrasound should be the initial imaging modality for suspected uncomplicated acute pancreatitis because it is radiation-free and provides a reasonably good look at the pancreas.

Lipase has a half-life of approximately 7 days and is more specific for pancreatic pathology than amylase, which can be elevated in appendicitis, gynecologic conditions, and salivary gland disease.

Amylase rises and normalizes much more quickly than lipase, so in patients presenting 2 days after symptom onset, amylase may not be elevated while lipase remains diagnostic.

The primary value of ultrasound in acute pancreatitis is screening for biliary causes (CBD dilation, gallstones) rather than documenting pancreatitis or looking for complications.

CT is the imaging modality of choice for suspected complicated pancreatitis, providing superior visualization of necrosis, fluid collections, hemorrhage, and masses compared to ultrasound.

MRCP is not the optimal imaging modality during an acute pancreatitis attack because edema obscures ductal anatomy; it should be reserved for workup of biliary and pancreatic ductal issues after inflammation resolves.

There is no data identifying a superior pain medication for acute pancreatitis in adults, and opioids can be used appropriately in the right setting without delaying recovery.

Early enteral nutrition (within 24–72 hours) in acute pancreatitis is associated with favorable outcomes including maintained gut barrier function, inhibited bacterial translocation, and lower incidence of systemic inflammatory response.

Nasogastric (NG) feeds have similar outcomes to nasojejunal (NJ) feeds in acute pancreatitis, including in severe cases, with no added benefit from bypassing the ampulla of Vater.

In a pediatric study of 38 admissions for mild pancreatitis, early nutrition was safe and feasible, with patients receiving feeds having similar pain scores to NPO patients.

There is no good evidence supporting low-fat diet restrictions in acute pancreatitis, though fat stimulates lipase secretion.

Pilot data showed patients who consumed the most fat during acute pancreatitis hospitalization had the lowest pain scores, suggesting patients self-regulate intake appropriately.

In a study of 201 pediatric pancreatitis patients, those receiving early PO intake plus aggressive IV fluids (≥1.5× maintenance) had a 4.2% rate of severe pancreatitis vs. 35% in the NPO/low-fluid group.

Ranson's criteria have not been validated as sensitive or specific for predicting mortality in pediatric pancreatitis, despite initial promising studies starting in 2002.

A prognostic tool using white blood cell count, albumin, and lipase on admission can predict severe pancreatitis in approximately 70% of pediatric patients, though it requires further optimization.

For CT imaging of acute pancreatitis, a single portal venous phase is sufficient; multi-phase imaging is not needed in pediatric patients unless evaluating for masses.

Oral contrast is helpful in CT for pancreatitis to separate fluid-filled bowel loops from pancreatic fluid collections, but the exam can provide substantial information without it if the patient cannot tolerate oral contrast.

Prophylactic antibiotics are not indicated for mild acute pancreatitis or for sterile pancreatic necrosis; they should be reserved for suspected or confirmed infected necrosis.

When antibiotics are indicated for pancreatic necrosis, imipenem or third-generation cephalosporins are appropriate initial choices based on available evidence.

Comprehensive workup for acute recurrent pancreatitis includes inflammatory causes (IBD, celiac), systemic illnesses, mitochondrial diseases, cystic fibrosis, metabolic conditions (hypertriglyceridemia, hypercalcemia, kidney disease), anatomic evaluation (MRCP, possibly ERCP), and genetic testing for PRSS1, SPINK1, CFTR, and CTRC.

Aspiration of pancreatic necrosis to rule out infection should be reserved for cases of true clinical deterioration; in the absence of significant clinical worsening, avoid needle aspiration due to risk of introducing infection into sterile necrosis.

In adults, there is growing evidence for endoscopic necrosectomy via EUS-guided transmural approach showing positive outcomes, but pediatric evidence is extremely limited.

The added value of secretin-enhanced MRCP in pediatric pancreatitis is not well established; even adult literature shows limited evidence, though it may improve visualization of ductal anomalies in select cases.

In pediatric acute pancreatitis, increased weight percentile for age at first attack predicts recurrence, based on a 3-year prospective registry of 85 patients.

For pancreatic duct leak demonstrated on ERCP, therapeutic options include pancreatic sphincterotomy and pancreatic duct stent placement to direct flow along the path of least resistance and allow duct healing.